DUBLIN, Feb. 26, 2020 /PRNewswire/ -- Jazz
Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company
will webcast its corporate presentations at the following investor
conferences:
- Cowen 40th Annual Healthcare Conference in
Boston, MA on Tuesday, March 3, 2020 at 8:00 a.m. EST / 1:00 p.m.
GMT. Bruce Cozadd,
chairman and chief executive officer, will provide an overview of
the company and a business and financial update.
- Barclays Global Healthcare Conference in Miami Beach, FL on Tuesday, March 10, 2020 at 9:30 a.m. EDT / 1:30 p.m.
GMT. Daniel Swisher,
president and chief operating officer, will provide an overview of
the company and a business and financial update.
A live audio webcast of each presentation may be accessed from
the Investors section of the Jazz Pharmaceuticals website at
www.jazzpharmaceuticals.com. Please connect to the website
prior to the start of each presentation to ensure adequate time for
any software downloads that may be necessary to listen to the
webcast.
An archive of each webcast will be available for at least one
week following each presentation on the Investors section of the
company's website at www.jazzpharmaceuticals.com.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc
(Nasdaq: JAZZ) is a global biopharmaceutical company dedicated to
developing life-changing medicines for people with serious diseases
— often with limited or no options. We have a diverse
portfolio of marketed medicines and novel product candidates, from
early- to late-stage development, in key therapeutic areas.
Our focus is in neuroscience, including sleep medicine and
movement disorders, and in oncology, including hematologic and
solid tumors. We actively explore new options for patients
including novel compounds, small molecule advancements, biologics
and innovative delivery technologies. Jazz is headquartered
in Dublin, Ireland and has
employees around the globe, serving patients in more than 90
countries. For more information, please visit
www.jazzpharmaceuticals.com and follow @JazzPharma on Twitter.
Jazz
Pharmaceuticals Contacts:
|
|
Investors: Kathee Littrell
Vice President, Investor Relations
Ireland, +353 1 634 7887
U.S., +1 650 496 2717
|
Media: Jacqueline Kirby
Vice President, Corporate Affairs & Government Relations
Ireland, +353 1 697 2141
U.S., +1 215 867 4910
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-301011941.html
SOURCE Jazz Pharmaceuticals plc